Cervical cancer is the fourth most common cancer among women globally. The burden
faced by low-and middle-income countries is significantly greater than high-income …

Introduction The WHO recommends human papillomavirus (HPV) cervical self-sampling as
an additional screening method and HPV DNA testing as an effective approach for the early …

Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

Cervical cancer screening rates in the United States are generally high, yet certain groups
demonstrate disparities in screening and surveillance. Individuals at greatest risk for cervical …

In most industrialized countries, screening programs for cervical cancer have shifted from
cytology (Pap smear or ThinPrep) alone on clinician-obtained samples to the addition of …

The persisting burden of cervical cancer in underserved populations and low-resource
regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive …

BACKGROUND: Cervical cancer is the second-most common cancer among women in the
developing world and approximately 500,000 cases are diagnosed each year. In developed …

Introduction This study sought to characterize racial and ethnic disparities in cervical cancer
screening and follow-up of abnormal findings across 3 US healthcare settings. Methods …

Cervical cancer is the fourth most common cancer in women in the world. To eliminate
cervical cancer by 2030, the World Health Organization has given the target of 70 per cent …

The World Health Organization announced an ambitious call for cervical cancer elimination
worldwide. With existing prevention and treatment modalities, cervical cancer elimination is …